- Home
- OPT vs MX Comparison
OPT vs MX Comparison
Compare OPT & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- MX
- Stock Information
- Founded
- OPT 1984
- MX 2003
- Country
- OPT Australia
- MX South Korea
- Employees
- OPT N/A
- MX N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- MX Semiconductors
- Sector
- OPT Health Care
- MX Technology
- Exchange
- OPT Nasdaq
- MX Nasdaq
- Market Cap
- OPT 201.5M
- MX 188.0M
- IPO Year
- OPT 2020
- MX N/A
- Fundamental
- Price
- OPT $3.24
- MX $4.60
- Analyst Decision
- OPT Strong Buy
- MX Strong Buy
- Analyst Count
- OPT 2
- MX 2
- Target Price
- OPT $14.00
- MX $7.50
- AVG Volume (30 Days)
- OPT 10.8K
- MX 157.9K
- Earning Date
- OPT 08-30-2024
- MX 10-31-2024
- Dividend Yield
- OPT N/A
- MX N/A
- EPS Growth
- OPT N/A
- MX N/A
- EPS
- OPT N/A
- MX N/A
- Revenue
- OPT $261,859.00
- MX $214,305,000.00
- Revenue This Year
- OPT N/A
- MX $1.74
- Revenue Next Year
- OPT $55,563.16
- MX $18.18
- P/E Ratio
- OPT N/A
- MX N/A
- Revenue Growth
- OPT N/A
- MX N/A
- 52 Week Low
- OPT $1.60
- MX $4.25
- 52 Week High
- OPT $4.40
- MX $8.50
- Technical
- Relative Strength Index (RSI)
- OPT 70.30
- MX 50.00
- Support Level
- OPT $2.84
- MX $4.25
- Resistance Level
- OPT $3.19
- MX $4.83
- Average True Range (ATR)
- OPT 0.14
- MX 0.16
- MACD
- OPT 0.01
- MX 0.01
- Stochastic Oscillator
- OPT 100.00
- MX 75.76
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.